ÂÜÀòÂÒÂ×

Karen S. has worked in the field of pharmacovigilance and drug safety for over 14 years. Karen is currently the Director of Pharmacovigilance Sciences at Scholar Rock, where they have been since July 2022. Prior to this, they worked as the Associate Director, Pharmacovigilance Scientist, and Operation Lead at the same company from April 2020 to July 2022.

Before joining Scholar Rock, Karen worked at Covance as a Drug Safety Project Manager from June 2016 to April 2020. In this role, they were responsible for collecting and analyzing safety data from clinical trials and post-marketing settings, as well as overseeing the entire pharmacovigilance process.

From June 2014 to June 2016, Karen served as the Acting Manager of Drug Safety at PRA Health Sciences. In this role, they managed a team of four direct reports and was involved in various HR tasks. Karen also developed and implemented training for drug safety associates, assistants, and managers. Prior to this, they held the position of Senior Drug Safety Analyst and Drug Safety Analyst II at the same company, where they were involved in safety case processing, database maintenance, and regulatory submissions.

Karen's earlier experience includes working as a Drug Safety Analyst at Roche Pharmaceuticals from August 2009 to December 2010, where they collected and analyzed adverse events in clinical trials. Karen also worked as a Pharmacovigilance intern at Abbott Laboratories from June 2007 to November 2008, where they were involved in adverse event reporting and database improvement projects.

Overall, Karen has extensive experience in pharmacovigilance and drug safety, with a strong background in safety case processing, database management, regulatory submissions, and managing teams.

Karen S. attended USP - Universidade de São Paulo from 2005 to 2010, where they studied Pharmacy. No specific degree name was provided.